Table 4.
The BA-producing abilities of the isolated strains with corresponding precursor.
| Strain | Tryptamine (mg/L) | β-Phenethylamine (mg/L) | Putrescine (Ornithine monohydrochloride) (mg/L) | Putrescine (Agmatine sulfate salt) (mg/L) | Cadaverine (mg/L) | Histamine (mg/L) | Tyramine (mg/L) | Total (mg/L) |
|---|---|---|---|---|---|---|---|---|
| Sp | ND | 33.69 ± 6.69 ab | ND | ND | ND | ND | ND | 33.69 ± 6.69 a |
| Se | ND | ND | ND | ND | ND | ND | ND | ND |
| Sc1 | 155.83 ± 6.25 c | 428.33 ± 31.03 f | ND | ND | ND | ND | 18.35 ± 1.24 a | 602.51 ± 38.52 c |
| Sc2 | 94.50 ± 3.35 b | 166.95 ± 61.51 cd | ND | ND | ND | ND | ND | 261.45 ± 64.86 ab |
| Ss | ND | ND | ND | ND | ND | ND | ND | ND |
| Bs | ND | 23.53 ± 1.41 a | ND | ND | ND | ND | ND | 23.53 ± 1.41 a |
| Ba | ND | 20.93 ± 2.31 a | ND | 0.41 ± 0.17 a | ND | ND | ND | 21.34 ± 2.48 a |
| Bp | 274.04 ± 13.69 d | 100.44 ± 3.30 bc | ND | ND | ND | ND | ND | 374.48 ± 16.99 bc |
| Ef1 | 10.05 ± 0.12 a | 241.79 ± 3.55 de | ND | 7.81 ± 1.82 b | 5.74 ± 0.61 b | 18.72 ± 1.18 b | 1004.38 ± 33.87 bc | 1288.49 ± 41.15 e |
| Ef2 | 6.55 ± 2.62 a | 96.86 ± 14.73 abc | ND | 6.89 ± 1.69 b | ND | 21.29 ± 0.89 b | 1218.89 ± 49.39 c | 1350.48 ± 69.29 e |
| Ef3 | 11.14 ± 0.57 a | 261.17 ± 41.98 e | ND | ND | 6.14 ± 1.68 b | 19.68 ± 0.56 b | 1081.22 ± 85.36 bc | 1379.35 ± 130.15 e |
| Lc | 6.22 ± 0.71 a | ND | 172.25 ± 2.71 | 12.12 ± 1.10 c | 0.67 ± 0.34 a | ND | ND | 191.26 ± 4.86 ab |
| Cm | 7.01 ± 0.07 a | 57.33 ± 12.17 ab | ND | ND | ND | 9.56 ± 5.35 a | 817.84 ± 240.38 b | 891.74 ± 257.97 d |
Different letters (a, b, c, d, e, f) indicate significantly different means at P < 0.05 [analysis of variance (ANOVA)].